Is amiodarone an alternative to beta-blockers to treat supraventricular tachycardias in pheochromocytoma?

G. Solares,F. Ramos,R. Martín‐Durán,M. Ares
DOI: https://doi.org/10.1001/ARCHINTE.1986.00360220267048
1986-10-01
Archives of Internal Medicine
Abstract:To the Editor. —In the January 1984Archives, Sloand and Taylor Thompson1presented a case of unknown pheochromocytoma without histologic evidence of heart disease, in which propranolol hydrochloride—induced pulmonary edema and shock, leading to death. It is known that propranolol may cause pulmonary edema in patients with pheochromocytoma without having a previous α-blockade.2As propranolol is a nonspecific betablocking drug, its administration in these patients may leave α-adrenergic effects unopposed.1,2This could result in arterial vasoconstriction causing afterload increase and heart failure, that may lead to pulmonary edema2and cardiogenic shock.1Sloand and Taylor Thompson1suggested that the use of a selective β1-blocker such as metoprolol tartrate, would be a theoretical alternative to propranolol. Additionally, propranolol has a negative inotropic effect and because of this action, it has been reported to precipitate severe heart failure in a patient with a pheochromocytoma plus a cardiomyopathy, that was under a-adrenergic
What problem does this paper attempt to address?